Terms: = Kidney tumors AND KRAS, C-K-RAS, 3845, P01116, NS3, KI-RAS, KRAS2, K-RAS4A, K-RAS2A, K-RAS4B, KRAS1, K-RAS2B, RASK2 AND Staging
2 results:
1. Gene mutation profiling and clinical significances in patients with renal cell carcinoma.
Wang Y; He P; Zhou X; Wang C; Fu J; Zhang D; Liao D; Zhou Z; Wu C; Gong W
Clinics (Sao Paulo); 2023; 78():100259. PubMed ID: 37515929
[TBL] [Abstract] [Full Text] [Related]
2. Investigation of c-myc and K-ras amplification in renal clear cell adenocarcinoma.
Kozma L; Kiss I; Nagy A; Szakáll S; Ember I
Cancer Lett; 1997 Jan; 111(1-2):127-31. PubMed ID: 9022137
[TBL] [Abstract] [Full Text] [Related]
